Cognitive function in young and adult IL (interleukin)-6 deficient mice

Behavioural Brain Research

Volumn 153, Issue 2, 2004, Pages 423-429

  Braida, Daniela ^a   Sacerdote, Paola ^a   Panerai, Alberto E ^a   Bianchi, Mauro ^a   Aloisi, Anna Maria ^b   Iosuè, Stefania ^a   Sala, Mariaelvina ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Interleukin 6; Knock out mice; Reference memory; Working memory

Indexed keywords

CHOLINE ACETYLTRANSFERASE; CYTOKINE; INTERLEUKIN 6; SCOPOLAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; COGNITION; CONTROLLED STUDY; ENZYME ACTIVITY; EXPERIMENTAL MODEL; FEMALE; GENOTYPE; HIPPOCAMPUS; KNOCKOUT MOUSE; LATENT PERIOD; LEARNING; MALE; MAZE TEST; MOTOR PERFORMANCE; MOUSE; MUTANT; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TASK PERFORMANCE; WILD TYPE; WORKING MEMORY;

AGE FACTORS; ALZHEIMER DISEASE; ANIMALS; AVOIDANCE LEARNING; CHOLINE O-ACETYLTRANSFERASE; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; HUMANS; INTERLEUKIN-6; MAZE LEARNING; MEMORY, SHORT-TERM; MENTAL RECALL; MICE; MICE, KNOCKOUT; MICE, NEUROLOGIC MUTANTS; MICE, TRANSGENIC; MOTOR ACTIVITY; MUSCARINIC ANTAGONISTS; SCOPOLAMINE;

EID: 3242723955     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2003.12.018     Document Type: Article

References (44)

1. Alleva E., Citrulli F., Bianchi M., Bondiolotti G.P., Chiarotti F., De Acetis L., et al. Behavioural characterization of interleukin-6 overexpressing or deficient mice during agonistic encounters. Eur. J. Neurosci. 10:1998;3664-3672
2. Aloisi A.M., Albonetti M.E., Lodi L., Lupo C., Carli G. Decrease of hippocampal choline acetyltransferase activity induced by formalin pain. Brain Res. 269:1993;167-170
3. Armario A., Hernandez J., Bluethmann H., Hidalgo J. IL-6 deficiency leads to increased emotionally in mice: evidence in transgenic mice carrying a null mutation of IL-6. J. Neuroimmunol. 92:1998;160-169
4. Bauer J., Strauss S., Schreiter-Gasser U., Danter U., Schlegel P., Witt I., et al. Interleukin-6 and alpha-2-macroglubulin indicate an acute-phase syate in Alzheimer's disease cortices. FEBS Lett. 285:1991;111-114
5. Bellinger F.P., Madamba S.G., Campbell I.L., Siggins G.R. Reduced long-term potentation in the dentate gyrus of transgenic mice with cerebral overexpression of interleukin-6. Neurosci. Lett. 198:1995;95-98
6. Bernstein D., Olton D.S., Ingram D.K., Waller S.B., Reynolds M.A., London E.D. Radial maze performance in young and aged mice: neurochemical correlates. Pharmacol. Biochem. Behav. 22:1985;301-307
7. Besedowsky H.O., Del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr. Rev. 17:1996;64-102
8. Bianchi M., Ferrario P., Clavenna A., Panerai A.E. Interleukin-6 affects scopolamine-induced amnesia, but not brain amino acid levels in mice. NeuroReport. 8:1997;1775-1778
9. Bianchi M., Maggi R., Pimpinelli F., Rubino T., Parolaro D., et al. Presence of a reduced opioid response in interleukin-6 knock out mice. Eur. J. Neurosci. 11:1999;1501-1507
10. Bianchi M., Panerai A.E. Interleukin-2 enhances scopolamine-induced amnesia and hyperactivity in the mouse. NeuroReport. 4:1993;1046-1048
11. Bianchi M., Sacerdote P., Panerai A.E. Cytokines and cognitive functions in mice. Biol. Signals Recept. 7:1998;45-54
12. Bierley R.A., Rixen G.J., Troster A.I., Beatty W.W. Preserved spatial memory in old rats survives 10 months without training. Behav. Neural Biol. 45:1986;223-229
13. Butterweck V., Prinz S., Schwaninger M. The role of interleukin-6 in stress-induced hyperthermia and emotional behaviour in mice. Behav. Brain Res. 44:2003;49-56
14. Campbell I.L., Abraham C.R., Masliah E., Kemper P., Inglis J.D., Oldstone M.B.A., et al. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin-6. Proc. Natl. Acad. Sci. U.S.A. 90:1993;10061-10065
15. Clark W.M., Rinker L.G., Lessov N.S., Hazel K., Hill J.K., Stenzel-Poore M., et al. Lack of interleukin-6 expression is not protective against focal central nervous system ischemia. Stroke. 31:2000;1715-1720
16. D'Mello G.D., Steckler T. Animal models in cognitive behavioural pharmacology: an overview. Brain Res. Cogn. Brain Res. 3:1996;345-352
17. Dunbar G.L., Rylett R.J., Schmidt B.M., Sinclair R.C., Williams L.R. Hippocampal choline acetyltransferase activity correlates with spatial learning in aged rats. Brain Res. 604:1993;266-272
18. Fonnum F. A radiochemical method for the estimation of choline acetyltransferase. Biochem. J. 100:1966;479-484
19. Fredriksson A., Archer T. Alpha-phenyl-tert-butyl-nitrone (PBN) reverses age-related maze learning performance and motor activity deficits in C57 BL/6 mice. Behav. Pharmacol. 7:1996;245-253
20. Frick K.M., Gorman L.K., Markowska A.L. Oxotremorine infusions into the medial septal area of middle-aged rats affect spatial reference memory and ChAT activity. Behav. Brain Res. 80:1996;99-109
21. Gadient R.A., Otten U. Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6-R) mRNAs in rat brain during postnatal development. Brain Res. 15:1987;313-314
22. Gallo P., Frei K., Rordorf C., Lazdins J., Tavolato B., Fontana A. Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. J. Neuroimmunol. 23:1989;109-116
23. Heyser C.J., Masliah E., Samimi A., Campbell I.L., Gold L.H. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc. Natl. Acad. Sci. U.S.A. 94:1997;1500-1505
24. Hull M., Strauss S., Berger M., Volk B., Bauer J. The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease. Behav. Brain Res. 78:1996;37-41
25. Itoh J., Ukai M., Kameyama T. Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the mu-selective opioid receptor agonist DAMGO in mice. J. Pharmacol. Exp. Ther. 269:1994;15-21
26. Kishimoto T., Akira S., Taga T. Interleukin-6 and ist receptor: a paradigm for cytokines. Science. 258:1992;593-597
27. Lattanzio G., Libert C., Aquilina M., Cappelletti M., Ciliberto G., Musiani P., et al. Defective development of pristane-oil-induced plasmacytoma in interleukin-6-deficient balb/c mice. Am. J. Pathol. 151:1997;689-696
28. Loddick S.A., Turnbull A.V., Rothwell N.J. Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 18:1998;176-179
29. Ma T.C., Zhu X.Z. Effects of intrahippocampal infusion of interleukin-6 on passive avoidance and nitrite and prostaglandin levels in the hippocampus in rats. Arzneimittelforschung. 50:2000;227-231
30. Maeda Y., Matsumoto M., Hori H., Kuwabara K., Ogawa S., Du-Yan S., et al. Hypoxia/reoxygeneration-mediated induction of astrocyte interleukin-6: a paracrine mechanism potentially enhancing neuron survival. J. Exp. Med. 180:1994;2297-2308
31. Matsuda S, Wen TC, Morita F, Otsuka H, Igase K, Yoshimura H, et al. Interleukin-6 prevents ischemia-induced learning disability and neuronal and synaptic loss in gerbils. Neurosci Lett 1996;204:109-112.
32. McCann U.D., Rabin R.A., Winter J.C. Use of the radial maze in studies of phencyclidine and other drugs of abuse. Physiol. Behav. 40:1987;805-809
33. Olton D.S., Papas B.C. Spatial memory and hippocampal function. Neuropsychologia. 17:1979;669-682
34. Poli V., Balena R., Fattori E., Markatos A., Yamamoto M., Tanaka H., et al. IL-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J. 13:1994;1189-1196
35. Qiu Z., Sweeney B.D., Netzeband J.G., Gruol D.L. Chronic interleukin-6 alters NMDA receptor-mediated membrane responses and enhances neurotoxicity in developing CNS neurons. J. Neurosci. 18:1998;10445-10456
36. Reinstein D.K., DeBoissiere T., Robinson N., Wurtman R.J. Radial maze performance in three strains of mice: role of the fimbria/fornix. Brain Res. 263:1983;172-176
37. Robertson E., Bradley A., Kuehn M., Evans M. Germ-line transmission of genes introduced into cultured pluripotent cells by retroviral vector. Nature. 323:1986;445-448
38. Sala M., Braida D., Calcaterra P., Leone M.P., Comotti F.A., Gianola S., et al. Effect of centrally atropine and pirenzepine on radial maze performance in the rat. Eur. J. Pharmacol. 194:1991;45-49
39. Smith G. Animal models of Alzheimer's disease: experimental cholinergic denervation. Brain Res. 472:1988;103-118
40. Tha K.K., Okuma Y., Miyazaki H., Murayama T., Uehara T., Hatakeyama R. Changes in expressions of proinflammatory cytokines IL-1β, TNF-α and IL-6 in the brain of senescence accelerated mouse (SAM) P8. Brain Res. 885:2000;25-31
41. Ukai M., Watanabe Y., Kameyama T. Effects of endomorphins-1 and -2, endogenous mu-opioid receptor agonists, on spontaneous alternation performance in mice. Eur. J. Pharmacol. 395:2000;211-215
42. Ukai M., Lin H.P. Involvement of mu(1)-opioid receptors and cholinergic neurotransmission in the endomorphins-induced impairment of passive avoidance learning in mice. Behav. Brain Res. 129:2002;197-201
43. Van Snick J. Interleukin-6: an overview. Annu. Rev. Immunol. 8:1990;253-278
44. Zalcman S., Green-Johnson J.M., Murray L., Nance D.M., Dyck D., Anisman H., et al. Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Res. 643:1994;40-49